\-\ Texto\\:\\ \ \(0\)\
\-\ papillodema\\.\\ \ \(0\)\
\-\ ataxia\ \(76\)\
\-\ surgery\\ for\\ resection\\.\\ \\ since\\ a\\ gross\\ total\\ resection\\ was\\ accomplished\\ no\\ radiation\\ or\\ chemotherapy\\ is\\ contemplated\\ at\\ this\\ time\\.\ \(0\)\
\-\ ct\\:\\ there\\ is\\ hydrocephalus\\ of\\ both\\ lateral\\ and\\ the\\ third\\ ventricle\\.\\ \\ there\\ is\\ a\\ vermian\\ mass\\ overlying\\ the\\ fourth\\ ventricle\\ location\\.\\ \\ this\\ lesion\\ is\\ \\"cystic\\"\\ \\(fluid\\-like\\)\\ with\\ some\\ punctuate\\ calcification\\ seen\\ on\\ ct\\.\\ \\ on\\ the\\ mr\\,\\ there\\ is\\ some\\ peripheral\\ contrast\\ enhancement\\ of\\ the\\ mass\\.\ \(0\)\
\-\ pilomyxoid\\ astrocytoma\\ \\(pma\\)\\ who\\ grade\\ 2\ \(0\)\
\-\ pilocytic\\ astrocytoma\\ \\(who\\ gr\\ 1\\)\ \(0\)\
\-\ hemangioblastoma\\ \\(who\\ gr\\ 1\\)\ \(0\)\
\-\ pilomyxoid\\ astrocytoma\\ \\(who\\ gr\\ 2\\)\ \(0\)\
\-\ medulloblastoma\\ \\(who\\ gr\\ 4\\)\ \(0\)\
\-\ 13\\ y\\.o\\.\\ girl\\ developed\\ headaches\\ three\\ weeks\\ prior\\ to\\ admission\\.\\ \\ she\\ was\\ treated\\ at\\ that\\ time\\ with\\ medication\\ for\\ migraine\\ headache\\.\\ \\ one\\ day\\ before\\ presentation\\ she\\ developed\\ ataxia\\,\\ nausea\\,\\ and\\ vomiting\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ gr\\:\\ 0\\.48599273293149703\ \(0\)\
\-\ who\\:\\ 0\\.28073448039992205\ \(0\)\
\-\ pilomyxoid\\:\\ 0\\.27387540532061055\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.22479419916971016\ \(0\)\
\-\ ataxia\\:\\ 0\\.19276276584956015\ \(0\)\
\-\ developed\\:\\ 0\\.1472837678770137\ \(0\)\
\-\ papillodema\\:\\ 0\\.14667529729357745\ \(0\)\
\-\ pma\\:\\ 0\\.14667529729357745\ \(0\)\
\-\ ventricle\\:\\ 0\\.14612577193531956\ \(0\)\
\-\ punctuate\\:\\ 0\\.13693770266030528\ \(0\)\
\-\ is\\:\\ 0\\.13591346236055635\ \(0\)\
\-\ vermian\\:\\ 0\\.12755889393825262\ \(0\)\
\-\ resection\\:\\ 0\\.12725234406682778\ \(0\)\
\-\ some\\:\\ 0\\.12490532002607158\ \(0\)\
\-\ contemplated\\:\\ 0\\.12255308197728208\ \(0\)\
\-\ there\\:\\ 0\\.11848428679503704\ \(0\)\
\-\ she\\:\\ 0\\.11817277907977662\ \(0\)\
\-\ time\\:\\ 0\\.1176663691679068\ \(0\)\
\-\ migraine\\:\\ 0\\.11220488082640374\ \(0\)\
\-\ accomplished\\:\\ 0\\.10617950109804916\ \(0\)\
\-\ medulloblastoma\\:\\ 0\\.10307789271073768\ \(0\)\
\-\ hemangioblastoma\\:\\ 0\\.09926625108933067\ \(0\)\
\-\ pilocytic\\:\\ 0\\.09521312547192069\ \(0\)\
\-\ medication\\:\\ 0\\.0917419108148942\ \(0\)\
\-\ fourth\\:\\ 0\\.08900680303642633\ \(0\)\
\-\ gross\\:\\ 0\\.08808266551010835\ \(0\)\
\-\ overlying\\:\\ 0\\.08456364287299553\ \(0\)\
\-\ admission\\:\\ 0\\.08281630643213299\ \(0\)\
\-\ total\\:\\ 0\\.08132999483557242\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.08102736981293118\ \(0\)\
\-\ before\\:\\ 0\\.08024519317917214\ \(0\)\
\-\ the\\:\\ 0\\.07922289638603577\ \(0\)\
\-\ nausea\\:\\ 0\\.0762480317674764\ \(0\)\
\-\ mass\\:\\ 0\\.07582841180795234\ \(0\)\
\-\ ct\\:\\ 0\\.07557750228262189\ \(0\)\
\-\ third\\:\\ 0\\.07557726562515897\ \(0\)\
\-\ at\\:\\ 0\\.07498259890024071\ \(0\)\
\-\ 13\\:\\ 0\\.07486109457625559\ \(0\)\
\-\ headaches\\:\\ 0\\.0740388707436778\ \(0\)\
\-\ vomiting\\:\\ 0\\.07344673609639028\ \(0\)\
\-\ since\\:\\ 0\\.07190038169726512\ \(0\)\
\-\ grade\\:\\ 0\\.07137570375036341\ \(0\)\
\-\ peripheral\\:\\ 0\\.07097828516563673\ \(0\)\
\-\ calcification\\:\\ 0\\.0708663844571195\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.07048030363801917\ \(0\)\
\-\ girl\\:\\ 0\\.06962873309292142\ \(0\)\
\-\ was\\:\\ 0\\.06918533814107208\ \(0\)\
\-\ location\\:\\ 0\\.06911691677732895\ \(0\)\
\-\ headache\\:\\ 0\\.06842476017679708\ \(0\)\
\-\ presentation\\:\\ 0\\.06832809048257142\ \(0\)\
\-\ this\\:\\ 0\\.06821421164652794\ \(0\)\
\-\ three\\:\\ 0\\.06663025325848693\ \(0\)\
\-\ radiation\\:\\ 0\\.06577711669968986\ \(0\)\
\-\ mr\\:\\ 0\\.06422495800470332\ \(0\)\
\-\ day\\:\\ 0\\.06322614291680831\ \(0\)\
\-\ treated\\:\\ 0\\.06181124985115191\ \(0\)\
\-\ for\\:\\ 0\\.060169151542913975\ \(0\)\
\-\ on\\:\\ 0\\.05995571327551959\ \(0\)\
\-\ cystic\\:\\ 0\\.059780189092003506\ \(0\)\
\-\ weeks\\:\\ 0\\.059487736826276415\ \(0\)\
\-\ enhancement\\:\\ 0\\.05713162841215154\ \(0\)\
\-\ one\\:\\ 0\\.05683031352015928\ \(0\)\
\-\ prior\\:\\ 0\\.05553546424873446\ \(0\)\
\-\ both\\:\\ 0\\.055351573499416815\ \(0\)\
\-\ surgery\\:\\ 0\\.053365720713245836\ \(0\)\
\-\ lateral\\:\\ 0\\.049259954842540955\ \(0\)\
\-\ contrast\\:\\ 0\\.04822781672950923\ \(0\)\
\-\ lesion\\:\\ 0\\.047586869314580046\ \(0\)\
\-\ seen\\:\\ 0\\.046730232015364526\ \(0\)\
\-\ that\\:\\ 0\\.04307459006953087\ \(0\)\
\-\ and\\:\\ 0\\.041021225149762225\ \(0\)\
\-\ with\\:\\ 0\\.03887222180650373\ \(0\)\
\-\ of\\:\\ 0\\.03884900953256523\ \(0\)\
\-\ or\\:\\ 0\\.03453036365212523\ \(0\)\
\-\ no\\:\\ 0\\.032277827247417734\ \(0\)\
\-\ to\\:\\ 0\\.024814501125256273\ \(0\)\
